PRMT2 and malignant glioma: In the present study, we identify PRMT2 as a pro-tumorigenic factor in malignant gliomas and provide evidence that GBM cell growth and tumorigenesis is sensitive to PRMT2 depletion or inactivation in vitro and in vivo.